zevorcabtagene autoleucel
carsgen therapeutics
['multiple myeloma', 'zevorcabtagene', 'carsgen']
1/2, carsgen therapeutics announced #ash22 data presentations for ct053 (zevorcabtagene autoleucel), a bcma car-t cell therapy for patients with relapsed/refractory multiple myeloma (rrmm).
Research Intelligence, PharmaDJ, focus on China pharma & biotech industry and investment